Inizia
TopgOptions

ARDS upside potential

Long
TopgOptions  
NASDAQ:ARDS   None
Trend Analysis Technical Indicators Fundamental Analysis ARDS ardsstock aridis aridispharmaceuticals PHARMA pharmaceuticals pharmastocks Coronavirus (COVID-19) covidvaccine
8
0
trendanalysis indicator fundamental ards ardsstock aridis aridispharmaceuticals pharma pharmaceuticals pharmastocks coronavirus covidvaccine
ARDS Aridis Pharmaceuticals has 2 Phase 3 Clinical Trials for 2022, one Phase 2a study, a fully human monoclonal antibody (mAb) cocktail against COVID and a funding from the Gates Foundation to support development of inhaled formulation technology to deliver cost-effective monoclonal antibodies against influenza and COVID-19.

And the Market Cap is only 23.892Mil.

In my opinion this stock can double in trice anytime, their pipeline is highly undervalued.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.